Asthma: CaMKII is essential for the proasthmatic effects of oxidation

Science Translational Medicine

Volumn 5, Issue 195, 2013, Pages

  Sanders, Philip N ^a   Koval, Olha M ^a   Jaffer, Omar A ^a   Prasad, Anand M ^a   Businga, Thomas R ^a   Scott, Jason A ^a   Hayden, Patrick J ^b   Luczak, Elizabeth D ^a   Dickey, David D ^a   Allamargot, Chantal ^c   Olivier, Alicia K ^a   Meyerholz, David K ^a   Robison, Alfred J ^d   Winder, Danny G ^e   Blackwell, Timothy S ^e   Dworski, Ryszard ^e   Sammut, David ^f   Wagner, Brett A ^a   Buettner, Garry R ^a   Pope, Robert M ^c   Miller Jr , Francis J ^a,c   Dibbern, Megan E ^a   Haitchi, Hans Michael ^f   Mohler, Peter J ^g   Howarth, Peter H ^f   Zabner, Joseph ^a   Kline, Joel N ^a   Grumbach, Isabella M ^a,c,h   Anderson, Mark E ^a,c   more..

^a UNIVERSITY OF IOWA   (United States)

^b MATTEK CORPORATION   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g OHIO STATE UNIVERSITY   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCIN 5AC; PICROTOXIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; BENZYLAMINE DERIVATIVE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; OVALBUMIN; PROTEIN KINASE INHIBITOR; SULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; ENZYME METABOLISM; ENZYME REGULATION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHUS; ENZYMOLOGY; FEMALE; GENETICS; IN VITRO STUDY; INTRANASAL DRUG ADMINISTRATION; MALE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; DRUG ANTAGONISM;

ADMINISTRATION, INTRANASAL; ANIMALS; ASTHMA; BENZYLAMINES; BLOTTING, WESTERN; BRONCHI; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; FEMALE; HUMANS; IN VITRO TECHNIQUES; MALE; MICE; NADPH OXIDASE; OVALBUMIN; OXIDATION-REDUCTION; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; SULFONAMIDES;

EID: 84883015458     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006135     Document Type: Article

References (69)

1. S. B. Barnett, T. A. Nurmagambetov, Costs of asthma in the United States: 2002-2007. J. Allergy Clin. Immunol. 127, 145-152 (2011).
2. H. A. Kerstjens, M. Engel, R. Dahl, P. Paggiaro, E. Beck, M. Vandewalker, R. Sigmund, W. Seibold, P. Moroni-Zentgraf, E. D. Bateman, Tiotropium in asthma poorly controlled with standard combination therapy. N. Engl. J. Med. 367, 1198-1207 (2012).
3. N. N. Jarjour, W. J. Calhoun, Enhanced production of oxygen radicals in asthma. J. Lab. Clin. Med. 123, 131-136 (1994).
4. S. M. Casalino-Matsuda, M. E. Monzón, R. M. Forteza, Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium. Am. J. Respir. Cell Mol. Biol. 34, 581-591 (2006).
5. H. Abdala-Valencia, J. Earwood, S. Bansal, M. Jansen, G. Babcock, B. Garvy, M. Wills-Karp, J. M. Cook-Mills, Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L1111-L1125 (2007).
6. A. R. Hulsmann, H. R. Raatgeep, J. C. den Hollander, T. Stijnen, P. R. Saxena, K. F. Kerrebijn, J. C. de Jongste, Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am. J. Respir. Crit. Care Med. 149, 519-525 (1994).
7. J. R. Erickson, J. He, I. M. Grumbach, M. E. Anderson, CaMKII in the cardiovascular system: Sensing redox states. Physiol. Rev. 91, 889-915 (2011).
8. L. C. Griffith, Regulation of calcium/calmodulin-dependent protein kinase II activation by intramolecular and intermolecular interactions. J. Neurosci. 24, 8394-8398 (2004).
9. J. R. Erickson, M. L. Joiner, X. Guan, W. Kutschke, J. Yang, C. V. Oddis, R. K. Bartlett, J. S. Lowe, S. E. O'Donnell, N. Aykin-Burns, M. C. Zimmerman, K. Zimmerman, A. J. Ham, R. M. Weiss, D. R. Spitz, M. A. Shea, R. J. Colbran, P. J. Mohler, M. E. Anderson, A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133, 462-474 (2008).
10. +/calmodulin- dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. J. Clin. Invest. 119, 986-996 (2009).
11. +/calmodulin- dependent kinase II δ (CaMKIIδ) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21. J. Biol. Chem. 286, 7990-7999 (2011).
12. I. Dzhura, Y. Wu, R. J. Colbran, J. R. Balser, M. E. Anderson, Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat. Cell Biol. 2, 173-177 (2000).
13. P. D. Swaminathan, A. Purohit, S. Soni, N. Voigt, M. V. Singh, A. V. Glukhov, Z. Gao, B. J. He, E. D. Luczak, M. L. Joiner, W. Kutschke, J. Yang, J. K. Donahue, R. M. Weiss, I. M. Grumbach, M. Ogawa, P. S. Chen, I. Efimov, D. Dobrev, P. J. Mohler, T. J. Hund, M. E. Anderson, Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J. Clin. Invest. 121, 3277-3288 (2011).
14. B. J. He, M. L. Joiner, M. V. Singh, E. D. Luczak, P. D. Swaminathan, O. M. Koval, W. Kutschke, C. Allamargot, J. Yang, X. Guan, K. Zimmerman, I. M. Grumbach, R. M. Weiss, D. R. Spitz, C. D. Sigmund, W. M. Blankesteijn, S. Heymans, P. J. Mohler, M. E. Anderson, Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat. Med. 17, 1610-1618 (2011).
15. M. E. Munroe, T. R. Businga, J. N. Kline, G. A. Bishop, Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma. J. Immunol. 185, 5586-5597 (2010).
16. A. P. Moreira, K. A. Cavassani, U. B. Ismailoglu, R. Hullinger, M. P. Dunleavy, D. A. Knight, S. L. Kunkel, S. Uematsu, S. Akira, C. M. Hogaboam, The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J. Clin. Invest. 121, 4420-4432 (2011).
17. C. S. Park, T. B. Kim, K. Y. Lee, K. A. Moon, Y. J. Bae, M. K. Jang, Y. S. Cho, H. B. Moon, Increased oxidative stress in the airway and development of allergic inflammation in a mouse model of asthma. Ann. Allergy Asthma Immunol. 103, 238-247 (2009).
18. R. A. Clark, Activation of the neutrophil respiratory burst oxidase. J. Infect. Dis. 179 (Suppl. 2), S309-S317 (1999).
19. G. R. Buettner, B. A. Jurkiewicz, Ascorbate free radical as a marker of oxidative stress: An EPR study. Free Radic. Biol. Med. 14, 49-55 (1993).
20. R. K. Ikeda, J. Nayar, J. Y. Cho, M. Miller, M. Rodriguez, E. Raz, D. H. Broide, Resolution of airway inflammation following ovalbumin inhalation: Comparison of ISS DNA and corticosteroids. Am. J. Respir. Cell Mol. Biol. 28, 655-663 (2003).
21. J. Moskovitz, S. Bar-Noy, W. M. Williams, J. Requena, B. S. Berlett, E. R. Stadtman, Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. U.S.A. 98, 12920-12925 (2001).
22. L. A. Hart, V. L. Krishnan, I. M. Adcock, P. J. Barnes, K. F. Chung, Activation and localization of transcription factor, nuclear factor-kB, in asthma. Am. J. Respir. Crit. Care Med. 158, 1585-1592 (1998).
23. T. Fujisawa, S. Velichko, P. Thai, L. Y. Hung, F. Huang, R. Wu, Regulation of airway MUC5AC expression by IL-1β and IL-17A; the NF-κB paradigm. J. Immunol. 183, 6236-6243 (2009).
24. T. S. Blackwell, F. E. Yull, C. L. Chen, A. Venkatakrishnan, T. R. Blackwell, D. J. Hicks, L. H. Lancaster, J. W. Christman, L. D. Kerr, Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am. J. Respir. Crit. Care Med. 162, 1095-1101 (2000).
25. Y. Y. Xiang, S.Wang, M. Liu, J. A. Hirota, J. Li, W. Ju, Y. Fan, M. M. Kelly, B. Ye, B. Orser, P. M.O'Byrne, M. D. Inman, X. Yang, W. Y. Lu, A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat. Med. 13, 862-867 (2007).
26. J. A. Wagner, A. L. Cozens, H. Schulman, D. C. Gruenert, L. Stryer, P. Gardner, Activation of chloride channels in normal and cystic fibrosis airway epithelial cells by multifunctional calcium/calmodulin-dependent protein kinase. Nature 349, 793-796 (1991).
27. 2+-activated chloride channels in the apical activated membrane of cultured nonciliated human nasal epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L636-L646 (2005).
28. 2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem. Biophys. Res. Commun. 181, 968-975 (1991).
29. B. H. Chang, S. Mukherji, T. R. Soderling, Characterization of a calmodulin kinase II inhibitor protein in brain. Proc. Natl. Acad. Sci. U.S.A. 95, 10890-10895 (1998).
30. R. Zhang, M. S. Khoo, Y. Wu, Y. Yang, C. E. Grueter, G. Ni, E. E. Price Jr., W. Thiel, S. Guatimosim, L. S. Song, E. C. Madu, A. N. Shah, T. A. Vishnivetskaya, J. B. Atkinson, V. V. Gurevich, G. Salama, W. J. Lederer, R. J. Colbran, M. E. Anderson, Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 11, 409-417 (2005).
31. D. Spina, Epithelium smooth muscle regulation and interactions. Am. J. Respir. Crit. Care Med. 158, S141-S145 (1998).
32. R. Whelan, C. Kim, M. Chen, J. Leiter, M. M. Grunstein, H. Hakonarson, Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle. Eur. Respir. J. 24, 559-567 (2004).
33. C. Pantano, J. L. Ather, J. F. Alcorn, M. E. Poynter, A. L. Brown, A. S. Guala, S. L. Beuschel, G. B. Allen, L. A. Whittaker, M. Bevelander, C. G. Irvin, Y. M. Janssen-Heininger, Nuclear factor-kB activation in airway epithelium induces inflammation and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 177, 959-969 (2008).
34. H. Hakonarson, N. Maskeri, C. Carter, M. M. Grunstein, Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 103, 1077-1087 (1999).
35. S. T. Holgate, P. M. Lackie, D. E. Davies, W. R. Roche, A. F. Walls, The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin. Exp. Allergy 29 (Suppl. 2), 90-95 (1999).
36. P. Kuna, [Long-term effects of steroid therapy]. Wiad. Lek. 51 (Suppl. 1), 12-18 (1998).
37. phox-/- mice. J. Immunol. 168, 3974-3982 (2002).
38. U. C. Yadav, L. Aguilera-Aguirre, K. V. Ramana, I. Boldogh, S. K. Srivastava, Aldose reductase inhibition prevents metaplasia of airway epithelial cells. PLoS One 5, e14440 (2010).
39. H. Y. Kim, R. H. Dekruyff, D. T. Umetsu, The many paths to asthma: Phenotype shaped by innate and adaptive immunity. Nat. Immunol. 11, 577-584 (2010).
40. M. Geiszt, J. Witta, J. Baffi, K. Lekstrom, T. L. Leto, Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 17, 1502-1504 (2003).
41. 2+/CaM kinase II are necessary for VCAM-1 induction in IL-1β-treated human tracheal smooth muscle cells. Toxicol. Appl. Pharmacol. 237, 8-21 (2009).
42. X. Liu, M. Yao, N. Li, C. Wang, Y. Zheng, X. Cao, CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 112, 4961-4970 (2008).
43. K. Asehnoune, D. Strassheim, S. Mitra, J. Y. Kim, E. Abraham, Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J. Immunol. 172, 2522-2529 (2004).
44. N. L. Reynaert, A. van der Vliet, A. S. Guala, T. McGovern, M. Hristova, C. Pantano, N. H. Heintz, J. Heim, Y. S. Ho, D. E. Matthews, E. F. Wouters, Y. M. Janssen-Heininger, Dynamic redox control of NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory κB kinase β. Proc. Natl. Acad. Sci. U.S.A. 103, 13086-13091 (2006).
45. B. H. Segal, W. Han, J. J. Bushey, M. Joo, Z. Bhatti, J. Feminella, C. G. Dennis, R. R. Vethanayagam, F. E. Yull, M. Capitano, P. K. Wallace, H. Minderman, J. W. Christman, M. B. Sporn, J. Chan, D. C. Vinh, S. M. Holland, L. R. Romani, S. L. Gaffen, M. L. Freeman, T. S. Blackwell, NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One 5, e9631 (2010).
46. M. A. Koay, J. W. Christman, B. H. Segal, A. Venkatakrishnan, T. R. Blackwell, S. M. Holland, T. S. Blackwell, Impaired pulmonary NF-κB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice. Infect. Immun. 69, 5991-5996 (2001).
47. S. Y. Kim, K. A. Moon, H. Y. Jo, S. Jeong, S. H. Seon, E. Jung, Y. S. Cho, E. Chun, K. Y. Lee, Antiinflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation. Immunol. Cell Biol. 90, 441-448 (2012).
48. phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182, 751-758 (1995).
49. J. W. Tichelaar, W. Lu, J. A. Whitsett, Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J. Biol. Chem. 275, 11858-11864 (2000).
50. Z. M. Novakovic, M. C. Leinung, D. W. Lee, P. Grasso, Intranasal administration of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, enhances total uptake and bioavailability in Swiss Webster mice when compared to intraperitoneal, subcutaneous, and intramuscular delivery systems. Regul. Pept. 154, 107-111 (2009).
51. + channel-overexpressing mice: Role of TNF-α and IL-4Rα signaling, influence of neonatal development, and limited efficacy of glucocorticoid treatment. J. Immunol. 182, 4357-4367 (2009).
52. H. Li, W. Li, A. K. Gupta, P. J. Mohler, M. E. Anderson, I. M. Grumbach, Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 298, H688-H698 (2010).
53. A. C. Grobe, S. M. Wells, E. Benavidez, P. Oishi, A. Azakie, J. R. Fineman, S. M. Black, Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: Role of NADPH oxidase and endothelial NO synthase. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L1069-L1077 (2006).
54. Y. You, E. J. Richer, T. Huang, S. L. Brody, Growth and differentiation of mouse tracheal epithelial cells: Selection of a proliferative population. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L1315-L1321 (2002).
55. J. R. Wiśniewski, A. Zougman, N. Nagaraj, M. Mann, Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362 (2009).
56. M. Singer, J. Lefort, B. B. Vargaftig, Granulocyte depletion and dexamethasone differentially modulate airways hyperreactivity, inflammation, mucus accumulation, and secretion induced by rmIL-13 or antigen. Am. J. Respir. Cell Mol. Biol. 26, 74-84 (2002).
57. G. S. Roh, Y. Shin, S. W. Seo, B. R. Yoon, S. Yeo, S. J. Park, J. W. Cho, K. Kwack, Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics 4, 3318-3327 (2004).
58. 2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J. Clin. Invest. 119, 1230-1240 (2009).
59. R. D. Anderson, R. E. Haskell, H. Xia, B. J. Roessler, B. L. Davidson, A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 7, 1034-1038 (2000).
60. P. H. Karp, T. O. Moninger, S. P. Weber, T. S. Nesselhauf, J. L. Launspach, J. Zabner, M. J. Welsh, An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Methods Mol. Biol. 188, 115-137 (2002).
61. P. D. Vermeer, R. Harson, L. A. Einwalter, T. Moninger, J. Zabner, Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. Am. J. Respir. Cell Mol. Biol. 28, 286-295 (2003).
62. F. J. Miller Jr., X. Chu, B. Stanic, X. Tian, R. V. Sharma, R. L. Davisson, F. S. Lamb, A differential role for endocytosis in receptor-mediated activation of Nox1. Antioxid. Redox Signal. 12, 583-593 (2010).
63. H. J. Woo, C. H. Bae, S. Y. Song, Y. W. Kim, H. M. Lee, Y. D. Kim, Expression of glutaredoxin-1 in nasal polyps and airway epithelial cells. Am. J. Rhinol. Allergy 23, 288-293 (2009).
64. M. V. Singh, P. D. Swaminathan, E. D. Luczak, W. Kutschke, R. M. Weiss, M. E. Anderson, MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. J. Mol. Cell. Cardiol. 52, 1135-1144 (2012).
65. B. A. Wagner, S. Venkataraman, G. R. Buettner, The rate of oxygen utilization by cells. Free Radic. Biol. Med. 51, 700-712 (2011).
66. R. Dworski, H. U. Simon, A. Hoskins, S. Yousefi, Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J. Allergy Clin. Immunol. 127, 1260-1266 (2011).
67. R. Djukanović, J. W. Wilson, C. K. Lai, S. T. Holgate, P. H. Howarth, The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am. Rev. Respir. Dis. 143, 772-777 (1991).
68. -- secreting epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 87, 4956-4960 (1990).
69. British Thoracic Society Scottish Intercollegiate Guidelines Network, British Guideline on the Management of Asthma. Thorax 63 (Suppl. 4), iv1-121 (2008).